HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target.
HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $3 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target.
Related Posts
This Small Biotech Company Touts Promising Data For Alzheimer’s Candidate
BioVie Inc (NASDAQ:BIVI) announced topline results from an investigator-Sponsored Phase 2 trial of NE3107 for Alzheimer’s Disease (AD). The company says…
Nauticus Robotics Inks Offshore Service Contract With Shell
Nauticus Robotics Inc (NASDAQ: KITT) has entered into a service contract with Shell plc (NYSE:
Google Pledges $2B For Data Centre And Cloud Services In Malaysia
The data and cloud centers will be positioned in the Elmina Business Park, in central Selangor state, owned by Sime Darby Property.